All Stories

  1. Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance

    Article • Proceedings of the National Academy of Sciences, March 2026, Proceedings of the National Academy of Sciences

    Prof. Guido Kroemer

  2. Acyl-CoA-binding protein as a driver of pathological aging

    Article • Proceedings of the National Academy of Sciences, July 2025, Proceedings of the National Academy of Sciences

    Prof. Guido Kroemer

  3. An antibody against ACBP/DBI protects the heart, liver and lung against multiple types of injury

    Article • Proceedings of the National Academy of Sciences, October 2022, Proceedings of the National Academy of Sciences

    Prof. Guido Kroemer

  4. Cystic Fibrosis: New Insights into Therapeutic Approaches

    Article • Current Respiratory Medicine Reviews, January 2020, Bentham Science Publishers

    Prof. Guido Kroemer

  5. The elusive “hunger protein”: an appetite-stimulatory factor that is overabundant in human obesity

    Article • Molecular & Cellular Oncology, October 2019, Taylor & Francis

    Prof. Guido Kroemer

  6. Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies

    Article • OncoImmunology, October 2019, Taylor & Francis

    Prof. Guido Kroemer

  7. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

    Article • OncoImmunology, September 2019, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  8. Suppression of tumor antigen presentation during aneuploid tumor evolution contributes to immune evasion

    Article • OncoImmunology, September 2019, Taylor & Francis

    Prof. Guido Kroemer

  9. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor

    Article • Autophagy, September 2019, Taylor & Francis

    Prof. Guido Kroemer

  10. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity

    Article • OncoImmunology, September 2019, Taylor & Francis

    Prof. Guido Kroemer

  11. Contribution of annexin A1 to anticancer immunosurveillance

    Article • OncoImmunology, August 2019, Taylor & Francis

    Professor Peter van Endert, Prof. Guido Kroemer

  12. Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade

    Article • OncoImmunology, July 2019, Taylor & Francis

    Prof. Guido Kroemer

  13. Trial watch: dendritic cell vaccination for cancer immunotherapy

    Article • OncoImmunology, July 2019, Taylor & Francis

    Prof. Guido Kroemer

  14. 4,4'Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effects

    Article • Autophagy, June 2019, Taylor & Francis

    Prof. Guido Kroemer

  15. Caloric restriction promotes the stemness and antitumor activity of T lymphocytes

    Article • OncoImmunology, May 2019, Taylor & Francis

    Prof. Guido Kroemer

  16. Autophagy represses hepatic carcinogenesis

    Article • Molecular & Cellular Oncology, May 2019, Taylor & Francis

    Prof. Guido Kroemer

  17. A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers

    Article • OncoImmunology, April 2019, Taylor & Francis

    Marion Leduc, Prof. Guido Kroemer

  18. Tumor lysis with LTX-401 creates anticancer immunity

    Article • OncoImmunology, April 2019, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  19. Crizotinib – a tyrosine kinase inhibitor that stimulates immunogenic cell death

    Article • OncoImmunology, April 2019, Taylor & Francis

    Prof. Guido Kroemer

  20. Trial watch: dietary interventions for cancer therapy

    Article • OncoImmunology, April 2019, Taylor & Francis

    Dr Jonathan G Pol, FERRERE Gladys, Prof. Guido Kroemer

  21. Metabolic enzymes expressed by cancer cells impact the immune infiltrate

    Article • OncoImmunology, March 2019, Taylor & Francis

    Maria Castedo, Prof. Guido Kroemer

  22. Failure of immunosurveillance accelerates aging

    Article • OncoImmunology, February 2019, Taylor & Francis

    Prof. Guido Kroemer

  23. Etiological involvement of CFTR in apparently unrelated human diseases

    Article • Molecular & Cellular Oncology, December 2018, Taylor & Francis

    Prof. Guido Kroemer

  24. Anticancer effects of anti-CD47 immunotherapy in vivo

    Article • OncoImmunology, December 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  25. Spermidine reduces cancer-related mortality in humans

    Article • Autophagy, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  26. The intimate relationship between gut microbiota and cancer immunotherapy

    Article • Gut Microbes, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  27. Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate

    Article • OncoImmunology, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  28. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells

    Article • OncoImmunology, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  29. Trial Watch: Toll-like receptor agonists in cancer immunotherapy

    Article • OncoImmunology, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  30. Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans?

    Article • Autophagy, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  31. Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions

    Article • Molecular & Cellular Oncology, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  32. Methionine restriction for improving progeria: another autophagy-inducing anti-aging strategy?

    Article • Autophagy, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  33. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy

    Article • OncoImmunology, October 2018, Taylor & Francis

    Prof. Guido Kroemer

  34. Trial watch: peptide-based vaccines in anticancer therapy

    Article • OncoImmunology, September 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  35. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

    Article • OncoImmunology, August 2018, Taylor & Francis

    Dr Jonathan G Pol, Mathieu Crupi, Prof. Guido Kroemer

  36. TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

    Article • OncoImmunology, August 2018, Taylor & Francis

    Prof. Guido Kroemer

  37. Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts

    Article • OncoImmunology, June 2018, Taylor & Francis

    Prof. Guido Kroemer , Dr Jonathan G Pol

  38. Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations

    Article • Autophagy, June 2018, Taylor & Francis

    Dr P Bernard Fourie, Maria Vaccaro, Daniel Klionsky, Prof. Guido Kroemer

  39. Repurposing therapies for the personalised treatment of cystic fibrosis

    Article • Expert Opinion on Orphan Drugs, June 2018, Taylor & Francis

    Prof. Guido Kroemer

  40. Immune effectors responsible for the elimination of hyperploid cancer cells

    Article • OncoImmunology, May 2018, Taylor & Francis

    Prof. Guido Kroemer

  41. The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1

    Article • OncoImmunology, April 2018, Taylor & Francis

    Prof. Guido Kroemer

  42. Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

    Article • OncoImmunology, February 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  43. Mitochondrial permeability transition involves dissociation of F 1 F O ATP synthase dimers and C‐ring conformation

    Article • EMBO Reports, May 2017, EMBO

    Professor Paolo Pinton, Prof. Guido Kroemer

  44. Trial watch: Dendritic cell-based anticancer immunotherapy

    Article • OncoImmunology, May 2017, Taylor & Francis

    Abhishek Garg, Monica Vara-Perez, Prof. Guido Kroemer

  45. Se manger soi-même, avec modération, une condition pour garder un esprit sain dans un corps sain

    Article • médecine/sciences, March 2017, EDP Sciences

    Prof. Guido Kroemer

  46. The oncolytic peptide LTX-315 triggers necrotic cell death

    Article • Cell Cycle, November 2015, Taylor & Francis

    Prof. Guido Kroemer